Intriguingly, extensive in vitro and in vivo studies performed by the authors revealed that KRAS-driven pancreatic ductal adenocarcinomas display a dependency on glycolysis and the need to buffer intracellular pH through the bicarbonate producing activity of CA IX. Here, KRAS is linked to pancreatic ductal adenocarcinoma.